Montelukast Amarox (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This prevents leukotriene D4 from binding, thereby reducing bronchoconstriction, mucus production, and inflammatory cell recruitment in the respiratory tract.

The appropriate dose of Montelukast Amarox is determined by the prescribing healthcare professional based on the patient’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for montelukast in pregnancy are limited, so it should be used only if the potential benefit justifies the risk. During breastfeeding, the drug passes into milk in small amounts; use is recommended only when the benefit to the mother outweighs possible risks to the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients with allergic components or exercise‑induced symptoms, but it does not replace rescue bronchodilators for acute attacks.

Store Montelukast Amarox at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, humidity and direct sunlight to maintain product stability.

Montelukast Amarox is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water; it should not be crushed, chewed, or split unless specifically instructed by a healthcare professional.

Serious risks include allergic reactions such as rash, angioedema, or anaphylaxis, as well as neuropsychiatric events like depression, anxiety, or suicidal thoughts. Any sudden mood changes or severe allergic symptoms should prompt immediate medical attention.

Montelukast is contraindicated in individuals with known hypersensitivity to montelukast or any component of the formulation. Patients with uncontrolled severe liver disease should avoid use, and it should be prescribed with caution in children under the age approved for the specific dosage form.